Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  FUJIFILM Holdings Corporation    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FUJIFILM : Japan researchers say ozone effective in neutralising coronavirus

share with twitter share with LinkedIn share with facebook
08/26/2020 | 05:00am EDT

TOKYO, Aug 26 (Reuters) - Japanese researchers said on Wednesday that low concentrations of ozone can neutralise coronavirus particles, potentially providing a way for hospitals to disinfect examination rooms and waiting areas.

Scientists at Fujita Health University told a news conference they had proven that ozone gas in concentrations of 0.05 to 0.1 parts per million (ppm), levels considered harmless to humans, could kill the virus.

The experiment used an ozone generator in a sealed chamber with a sample of coronavirus. The potency of the virus declined by more than 90% when subjected to low level ozone for 10 hours.

"Transmission of the novel coronavirus may be reduced by continuous, low-concentration ozone treatment, even in environments where people are present, using this kind of system," said lead researcher Takayuki Murata.

"We found it to be particularly effective in high-humidity conditions."

Ozone, a type of oxygen molecule, is known to inactivate many pathogens, and previously experiments have shown that high concentrations, between 1-6 ppm, were effective against the coronavirus but potentially toxic to humans.

A recent study at the Georgia Institute of Technology showed that ozone may be effective in disinfecting gowns, goggles and other medical protective equipment.

Fujita Medical University Hospital, in Aichi prefecture central Japan, has installed ozone generators to reduce infection in waiting areas and patient rooms.

The university has also performed a clinical trial of Fujifilm Holdings Corp's Avigan drug on COVID-19 patients. (Reporting by Rocky Swift Editing by Robert Birsel)


Stocks mentioned in the article
ChangeLast1st jan.
AICHI CORPORATION -1.33% 893 End-of-day quote.19.71%
FUJIFILM HOLDINGS CORPORATION 0.65% 5397 End-of-day quote.3.19%
share with twitter share with LinkedIn share with facebook
All news about FUJIFILM HOLDINGS CORPORATION
10/22FUJIFILM : Fuji Xerox in court over alleged unfair contract terms
AQ
10/22Dr Reddy's isolates data center services after cyberattack
RE
10/22Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan
RE
10/22Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan
RE
10/19Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
RE
10/16Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
RE
10/15REFILE-UPDATE 3-Fujifilm seeks approval for Avigan as COVID-19 treatment in J..
RE
10/15FUJIFILM : applies for approval of Avigan as COVID-19 treatment in Japan
RE
10/08Eli Lilly in deal to supply COVID-19 drugs to low-income countries
RE
10/08Eli Lilly in deal to supply COVID-19 drugs to low-income countries
RE
More news
Financials
Sales 2021 2 202 B 21 020 M 21 020 M
Net income 2021 122 B 1 168 M 1 168 M
Net Debt 2021 191 B 1 826 M 1 826 M
P/E ratio 2021 17,4x
Yield 2021 1,78%
Capitalization 2 157 B 20 590 M 20 598 M
EV / Sales 2021 1,07x
EV / Sales 2022 1,00x
Nbr of Employees 73 906
Free-Float 73,8%
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
FUJIFILM Holdings Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FUJIFILM HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 5 988,00 JPY
Last Close Price 5 397,00 JPY
Spread / Highest target 26,0%
Spread / Average Target 11,0%
Spread / Lowest Target -6,99%
EPS Revisions
Managers
NameTitle
Shigetaka Komori Chairman & Group Chief Executive Officer
Kenji Sukeno President, Group COO & Representative Director
Takashi Iwasaki Director & Chief Technology Officer
Kouichi Tamai Director & Vice President
Takatoshi Ishikawa Director
Sector and Competitors
1st jan.Capitalization (M$)
FUJIFILM HOLDINGS CORPORATION3.19%20 590
CANON INC.-42.06%17 272
RICOH COMPANY, LTD.-41.69%4 805
BROTHER INDUSTRIES, LTD.-28.62%4 020
TOSHIBA TEC CORPORATION-5.86%2 233
GLORY LTD.-30.54%1 326